These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6803540)

  • 21. Immunoinhibition of ristocetin-induced platelet aggregation.
    Nachman RL; Jaffe EA; Weksler BB
    J Clin Invest; 1977 Jan; 59(1):143-8. PubMed ID: 299747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of calcium-dependent binding of endogenous factor VIII/von Willebrand factor to surface activated platelets.
    Furby FH; Berndt MC; Castaldi PA; Koutts J
    Thromb Res; 1984 Sep; 35(5):501-11. PubMed ID: 6435280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesion of human platelets to purified solid-phase von Willebrand factor: studies of normal and Bernard-Soulier platelets.
    Olson JD; Moake JL; Collins MF; Michael BS
    Thromb Res; 1983 Oct; 32(2):115-22. PubMed ID: 6419373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets.
    Nesheim ME; Pittman DD; Wang JH; Slonosky D; Giles AR; Kaufman RJ
    J Biol Chem; 1988 Nov; 263(31):16467-70. PubMed ID: 3141407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of ristocetin on platelets.
    Koutts J; Stott L; Firkin BG
    Am J Hematol; 1976; 1(3):313-7. PubMed ID: 1087117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor VIII and human platelet aggregation. II. Characteristics of aggregation of human platelets by bovine factor VIII.
    Bottecchia D; Vermylen J
    Br J Haematol; 1976 Oct; 34(2):313-20. PubMed ID: 987797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of factor VIII to platelets in the presence of ristocetin.
    Zucker MB; Kim SJ; McPherson J; Grant RA
    Br J Haematol; 1977 Apr; 35(4):535-49. PubMed ID: 301398
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of human platelet aggregation by the proteolytic effect of streptokinase. Role of the human factor-VIII-related protein.
    Castillo R; Maragall S; Guisasola JA; Casals F; Profitós J; Ordinas A
    Haemostasis; 1976; 5(5):306-17. PubMed ID: 1087912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane.
    Berndt MC; Gregory C; Kabral A; Zola H; Fournier D; Castaldi PA
    Eur J Biochem; 1985 Sep; 151(3):637-49. PubMed ID: 3161731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.
    Fujimoto T; Ohara S; Hawiger J
    J Clin Invest; 1982 Jun; 69(6):1212-22. PubMed ID: 6282932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T; Koller E; Doleschel W
    Thromb Haemost; 1979 Oct; 42(3):832-7. PubMed ID: 505400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions among bovine and human factor VIII, ristocetin, and DL-polylysine in the induction of guinea pig platelet aggregation.
    Kuwahara SS; Malik M
    Physiol Chem Phys; 1979; 11(4):337-44. PubMed ID: 538097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII.
    Vermylen J; Bottecchia D; Szpilman H
    Br J Haematol; 1976 Oct; 34(2):321-30. PubMed ID: 974043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evans blue: a specific inhibitor of factor VIII-induced platelet agglutination.
    Kirby EP
    Thromb Diath Haemorrh; 1975 Dec; 34(3):770-9. PubMed ID: 1239827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific binding of phospholipid platelet-activating factor by human platelets.
    Valone FH; Coles E; Reinhold VR; Goetzl EJ
    J Immunol; 1982 Oct; 129(4):1637-41. PubMed ID: 6286773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.